Brief: IN8bio Inc - Preliminary Estimate That Net Loss For Three Ended June 30 Is Expected To Be About $7.2 Mln And $13.3 Mln Respectively
Aug 8 (Reuters) - IN8BIO, Inc. INAB.O :
* IN8BIO - PRELIMINARY ESTIMATE THAT NET LOSS FOR THREE AND
SIX
MONTHS ENDED JUNE 30 IS EXPECTED TO BE ABOUT $7.2 MILLION AND
$13.3 MILLION RESPECTIVELY
* IN8BIO, INC. - ESTIMATED THAT ITS CASH AS OF JUNE 30, 2022
WAS
APPROXIMATELY $25.7 MILLION
Source: [https://bit.ly/3Q6cBiR]
Further company coverage: INAB.O
Recent news on IN8bio
See all newsIN8bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biopharma firm IN8bio's Q2 net loss narrows as expenses decline
IN8bio Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: IN8BIO - Enters Capital On Demand Sales Agreement With Jonestrading For ATM Offering
IN8bio Q1 net loss narrows as R&D expenses fall